Global Parkinson's Disease Therapeutics Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Parkinson's Disease Therapeutics Market Overview

• 1.1 Product Overview and Scope of Parkinson's Disease Therapeutics
• 1.2 Classification of Parkinson's Disease Therapeutics by Type
  • 1.2.1 Global Parkinson's Disease Therapeutics Revenue by Type: 2015 VS 2019 VS 2025
  • 1.2.2 Global Parkinson's Disease Therapeutics Revenue Market Share by Type in 2019
  • 1.2.3 Medications Therapeutics
  • 1.2.4 Medical Devices Therapeutics
• 1.3 Global Parkinson's Disease Therapeutics Market by Application
  • 1.3.1 Overview: Global Parkinson's Disease Therapeutics Revenue by Application: 2015 VS 2019 VS 2025
  • 1.3.2 Under 40 Years Old
  • 1.3.3 40-65 Years Old
  • 1.3.4 Above 65 Years Old
• 1.4 Global Parkinson's Disease Therapeutics Market by Regions
  • 1.4.1 Global Parkinson's Disease Therapeutics Market Size by Regions: 2015 VS 2019 VS 2025
  • 1.4.2 Global Market Size of Parkinson's Disease Therapeutics (2015-2025)
  • 1.4.3 North America (USA, Canada and Mexico) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.4 Europe (Germany, France, UK, Russia and Italy) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.6 South America (Brazil, Argentina, Colombia) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)
  • 1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Parkinson's Disease Therapeutics Status and Prospect (2015-2025)

2 Company Profiles

• 2.1 GSK
  • 2.1.1 GSK Details
  • 2.1.2 GSK Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.1.3 GSK SWOT Analysis
  • 2.1.4 GSK Product and Services
  • 2.1.5 GSK Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.2 Kyowa Hakko Kirin Pharma
  • 2.2.1 Kyowa Hakko Kirin Pharma Details
  • 2.2.2 Kyowa Hakko Kirin Pharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.2.3 Kyowa Hakko Kirin Pharma SWOT Analysis
  • 2.2.4 Kyowa Hakko Kirin Pharma Product and Services
  • 2.2.5 Kyowa Hakko Kirin Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.3 Teva Pharmaceutical
  • 2.3.1 Teva Pharmaceutical Details
  • 2.3.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.3.3 Teva Pharmaceutical SWOT Analysis
  • 2.3.4 Teva Pharmaceutical Product and Services
  • 2.3.5 Teva Pharmaceutical Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.4 Novartis
  • 2.4.1 Novartis Details
  • 2.4.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.4.3 Novartis SWOT Analysis
  • 2.4.4 Novartis Product and Services
  • 2.4.5 Novartis Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.5 Akorn
  • 2.5.1 Akorn Details
  • 2.5.2 Akorn Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.5.3 Akorn SWOT Analysis
  • 2.5.4 Akorn Product and Services
  • 2.5.5 Akorn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.6 Boehringer Ingelheim
  • 2.6.1 Boehringer Ingelheim Details
  • 2.6.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.6.3 Boehringer Ingelheim SWOT Analysis
  • 2.6.4 Boehringer Ingelheim Product and Services
  • 2.6.5 Boehringer Ingelheim Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.7 Desitin Arzneimittel
  • 2.7.1 Desitin Arzneimittel Details
  • 2.7.2 Desitin Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.7.3 Desitin Arzneimittel SWOT Analysis
  • 2.7.4 Desitin Arzneimittel Product and Services
  • 2.7.5 Desitin Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.8 Merck
  • 2.8.1 Merck Details
  • 2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.8.3 Merck SWOT Analysis
  • 2.8.4 Merck Product and Services
  • 2.8.5 Merck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.9 Abbvie
  • 2.9.1 Abbvie Details
  • 2.9.2 Abbvie Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.9.3 Abbvie SWOT Analysis
  • 2.9.4 Abbvie Product and Services
  • 2.9.5 Abbvie Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.10 Astellas Pharma
  • 2.10.1 Astellas Pharma Details
  • 2.10.2 Astellas Pharma Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.10.3 Astellas Pharma SWOT Analysis
  • 2.10.4 Astellas Pharma Product and Services
  • 2.10.5 Astellas Pharma Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.11 Apokyn
  • 2.11.1 Apokyn Details
  • 2.11.2 Apokyn Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.11.3 Apokyn SWOT Analysis
  • 2.11.4 Apokyn Product and Services
  • 2.11.5 Apokyn Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.12 US WorldMeds
  • 2.12.1 US WorldMeds Details
  • 2.12.2 US WorldMeds Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.12.3 US WorldMeds SWOT Analysis
  • 2.12.4 US WorldMeds Product and Services
  • 2.12.5 US WorldMeds Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.13 Endo Pharmaceuticals
  • 2.13.1 Endo Pharmaceuticals Details
  • 2.13.2 Endo Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.13.3 Endo Pharmaceuticals SWOT Analysis
  • 2.13.4 Endo Pharmaceuticals Product and Services
  • 2.13.5 Endo Pharmaceuticals Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.14 Orion
  • 2.14.1 Orion Details
  • 2.14.2 Orion Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.14.3 Orion SWOT Analysis
  • 2.14.4 Orion Product and Services
  • 2.14.5 Orion Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.15 Valeant
  • 2.15.1 Valeant Details
  • 2.15.2 Valeant Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.15.3 Valeant SWOT Analysis
  • 2.15.4 Valeant Product and Services
  • 2.15.5 Valeant Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.16 F.Hoffmann-La Roche
  • 2.16.1 F.Hoffmann-La Roche Details
  • 2.16.2 F.Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.16.3 F.Hoffmann-La Roche SWOT Analysis
  • 2.16.4 F.Hoffmann-La Roche Product and Services
  • 2.16.5 F.Hoffmann-La Roche Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.17 Bausch Health
  • 2.17.1 Bausch Health Details
  • 2.17.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.17.3 Bausch Health SWOT Analysis
  • 2.17.4 Bausch Health Product and Services
  • 2.17.5 Bausch Health Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.18 Stada Arzneimittel
  • 2.18.1 Stada Arzneimittel Details
  • 2.18.2 Stada Arzneimittel Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.18.3 Stada Arzneimittel SWOT Analysis
  • 2.18.4 Stada Arzneimittel Product and Services
  • 2.18.3 Stada Arzneimittel Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)
• 2.19 H.Lundbeck
  • 2.19.1 H.Lundbeck Details
  • 2.19.2 H.Lundbeck Major Business and Total Revenue (Financial Highlights) Analysis
  • 2.19.3 H.Lundbeck SWOT Analysis
  • 2.19.4 H.Lundbeck Product and Services
  • 2.19.5 H.Lundbeck Parkinson's Disease Therapeutics Revenue, Gross Margin and Market Share (2018-2019)

3 Market Competition, by Players

• 3.1 Global Parkinson's Disease Therapeutics Revenue and Share by Players (2015-2020)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Parkinson's Disease Therapeutics Players Market Share
  • 3.2.2 Top 10 Parkinson's Disease Therapeutics Players Market Share
• 3.3 Market Competition Trend

4 Market Size by Regions

• 4.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Regions
• 4.2 North America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.3 Europe Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.4 Asia-Pacific Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.5 South America Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 4.6 Middle East & Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

5 North America Parkinson's Disease Therapeutics Revenue by Countries

• 5.1 North America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 5.2 USA Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 5.3 Canada Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 5.4 Mexico Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

6 Europe Parkinson's Disease Therapeutics Revenue by Countries

• 6.1 Europe Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 6.2 Germany Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.3 UK Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.4 France Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.5 Russia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 6.6 Italy Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

7 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries

• 7.1 Asia-Pacific Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 7.2 China Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.3 Japan Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.4 Korea Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.5 India Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 7.6 Southeast Asia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

8 South America Parkinson's Disease Therapeutics Revenue by Countries

• 8.1 South America Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 8.2 Brazil Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 8.3 Argentina Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

9 Middle East & Africa Revenue Parkinson's Disease Therapeutics by Countries

• 9.1 Middle East & Africa Parkinson's Disease Therapeutics Revenue by Countries (2015-2020)
• 9.2 Saudi Arabia Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 9.3 UAE Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 9.4 Egypt Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)
• 9.5 South Africa Parkinson's Disease Therapeutics Revenue and Growth Rate (2015-2020)

10 Market Size Segment by Type

• 10.1 Global Parkinson's Disease Therapeutics Revenue and Market Share by Type (2015-2020)
• 10.2 Global Parkinson's Disease Therapeutics Market Forecast by Type (2019-2024)
• 10.3 Medications Therapeutics Revenue Growth Rate (2015-2025)
• 10.4 Medical Devices Therapeutics Revenue Growth Rate (2015-2025)

11 Global Parkinson's Disease Therapeutics Market Segment by Application

• 11.1 Global Parkinson's Disease Therapeutics Revenue Market Share by Application (2015-2020)
• 11.2 Parkinson's Disease Therapeutics Market Forecast by Application (2019-2024)
• 11.3 Under 40 Years Old Revenue Growth (2015-2020)
• 11.4 40-65 Years Old Revenue Growth (2015-2020)
• 11.5 Above 65 Years Old Revenue Growth (2015-2020)

12 Global Parkinson's Disease Therapeutics Market Size Forecast (2021-2025)

• 12.1 Global Parkinson's Disease Therapeutics Market Size Forecast (2021-2025)
• 12.2 Global Parkinson's Disease Therapeutics Market Forecast by Regions (2021-2025)
• 12.3 North America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.4 Europe Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.5 Asia-Pacific Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.6 South America Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)
• 12.7 Middle East & Africa Parkinson's Disease Therapeutics Revenue Market Forecast (2021-2025)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology
• 14.2 Data Source
• 14.3 Disclaimer